Physician profile
Andrew C Johnson
NPI 1508296005
$156,910.69
in general payments reported to CMS, 2019-2025
8 companies · $49K in 2025
The $49K reported for 2025 was more than what 98% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $26K · 2021: $7,450 · 2022: $4,654 · 2023: $7,645 · 2024: $62K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $73K · Travel and Lodging: $22K · Honoraria: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $73,358.68 |
| Travel and Lodging | $21,700.25 |
| Honoraria | $13,089.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,089.49 |
| Food and Beverage | $703.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $89,773.28 | 2024-2025 | Education |
| Neocis INC. | $26,520.00 | 2020-2021 | |
| Sprintray INC | $25,280.48 | 2023-2024 | Pro 2 3d Printer |
| Carestream Dental, LLC | $6,361.92 | 2021-2023 | |
| Zest Holdings, LLC | $4,700.82 | 2020-2022 | |
| Biohorizons Implant Systems INC. | $3,506.79 | 2020-2024 | Biohorizons |
| Nobel Biocare USA | $721.40 | 2019-2023 | Nobelactive |
| Kerr Corporation | $46.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.